Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Biogen Pharmachem Industries has informed that a meeting of the Board of Directors of the Company will be held at registered office of the company on Monday, 23rd Day of March, 2026 to consider the declaration of issue of bonus shares in accordance with the applicable provisions and subject to approval of Shareholders of the Company.
The above information is a part of company’s filings submitted to BSE.
